Price T Rowe Associates Inc Catalent, Inc. Transaction History

Price T Rowe Associates Inc

$836 Billion
Q2 2024

A detailed history of Price T Rowe Associates Inc transactions in Catalent, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 4,909,943 shares of CTLT stock, worth $296 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,909,943

Previous 5,144,218 4.55%

Holding current value

$296 Million

Previous $290 Million 4.93%

% of portfolio

0.03%

Previous 0.04%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$53.58 - $57.02 $12.6 Million - $13.4 Million	-234,275 Reduced 4.55%	4,909,943 $276 Million
Q1 2024 May 15, 2024	SELL	$42.56 - $59.82 $140 Million - $196 Million	-3,283,122 Reduced 38.96%	5,144,218 $290 Million
Q4 2023 Feb 14, 2024	BUY	$32.18 - $46.57 $77.5 Million - $112 Million	2,408,236 Added 40.01%	8,427,340 $379 Million
Q3 2023 Nov 14, 2023	BUY	$44.2 - $50.2 $159 Million - $180 Million	3,595,039 Added 148.31%	6,019,104 $274 Million
Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $20.6 Million - $43.5 Million	646,674 Added 36.38%	2,424,065 $105 Million
Q1 2023 May 15, 2023	SELL	$45.44 - $74.26 $12.7 Million - $20.7 Million	-279,416 Reduced 13.58%	1,777,391 $117 Million
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $5.14 Million - $10.1 Million	124,115 Added 6.42%	2,056,807 $92.6 Million
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $1.47 Billion - $2.3 Billion	-20,370,869 Reduced 91.33%	1,932,692 $140 Million
Q2 2022 Aug 15, 2022	BUY	$87.2 - $114.05 $175 Million - $229 Million	2,011,520 Added 9.91%	22,303,561 $2.39 Billion
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $158 Million - $209 Million	1,675,559 Added 9.0%	20,292,041 $2.25 Billion
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $7.85 Million - $9.13 Million	-65,681 Reduced 0.35%	18,616,482 $2.38 Billion
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $39.2 Million - $51.2 Million	-359,414 Reduced 1.89%	18,682,163 $2.49 Billion
Q2 2021 Aug 16, 2021	SELL	$100.34 - $115.69 $18.8 Million - $21.6 Million	-186,931 Reduced 0.97%	19,041,577 $2.06 Billion
Q1 2021 May 17, 2021	SELL	$101.51 - $125.27 $114 Million - $141 Million	-1,123,347 Reduced 5.52%	19,228,508 $2.02 Billion
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $1.75 Billion - $2.14 Billion	20,351,855 New	20,351,855 $2.12 Billion

Others Institutions Holding CTLT

# of Institutions

489

Shares Held

165M

Call Options Held

364K

Put Options Held

837K

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Catalent, Inc. Transaction History